Company Profile
Alpha Tau Medical Stock Price, News & Analysis
- Ticker:
- DRTS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Israel
Stock performance
12.99 USD (-2.04%)
Close
Last updated: August 6, 2026
807M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, DRTS closed down 2.04% at $12.99. No new same-company headline was identified in the current news window.
Company overview
Alpha Radiation Oncology Company
Alpha Tau Medical is an Israel-based oncology company developing Alpha DaRT, a single-use, minimally invasive, intratumoral alpha-radiation therapy. Originating at Tel Aviv University, the technology is designed to deliver high-energy alpha particles locally within solid tumors.
Pancreatic Cancer Evidence
At ASCO, the company presented a pooled analysis from three prospective Phase 1/2 studies in pancreatic ductal adenocarcinoma. The dataset included locally advanced and metastatic disease across first-line post-chemotherapy, second-line, and heavily pretreated settings, with encouraging survival and safety observations.
Local Treatment Strategy
Alpha DaRT is being developed as a local complement to systemic therapy rather than a replacement. The approach seeks to intensify tumor-directed treatment without adding substantial systemic toxicity to standard chemotherapy.
Solid Tumor Development Platform
Because Alpha DaRT is implanted directly into tumors, the platform may be evaluated across multiple accessible solid-tumor types. Pancreatic cancer is one active development setting within a broader strategy for localized alpha-particle treatment.
Future catalysts
Completion of enrollment in the U.S. multicenter IMPACT pancreatic cancer trial is the next identified milestone for Alpha DaRT in combination with first-line chemotherapy.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alpha Tau Medical (DRTS)?
Alpha Tau Medical (DRTS) most recently closed at 12.99 USD, a -2.04% move versus the previous session.
What is the market cap of Alpha Tau Medical (DRTS)?
Alpha Tau Medical currently has a market capitalization of 807M USD on BioPharmSignal.
What does Alpha Tau Medical do?
Alpha Radiation Oncology Company Alpha Tau Medical is an Israel-based oncology company developing Alpha DaRT, a single-use, minimally invasive, intratumoral alpha-radiation therapy. Originating at Tel Aviv University, the technology is designed to deliver high-energy alpha particles locally within solid tumors. Pancreatic Cancer Evidence At ASCO, the...
On which exchange is DRTS stock listed?
Alpha Tau Medical (DRTS) is associated with NASDAQ, Israel, Biopharma.
What is Alpha?
multicenter IMPACT pancreatic cancer trial is the next identified milestone for Alpha DaRT in combination with first-line chemotherapy.
Which conditions is Alpha Tau Medical targeting with Alpha?
Alpha Tau Medical is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Alpha Tau Medical describe recent progress with Alpha?
multicenter IMPACT pancreatic cancer trial is the next identified milestone for Alpha DaRT in combination with first-line chemotherapy.
What is Radiation?
Alpha Radiation Oncology Company Alpha Tau Medical is an Israel-based oncology company developing Alpha DaRT, a single-use, minimally invasive, intratumoral alpha-radiation therapy.